Biosimilar and Interchangeable Biologics: More Treatment Choices

The medical marketplace keeps growing as the U.S. Food and Drug Administration continues to approve more biosimilar products. Biosimilars can provide more treatment options to patients, potentially lowering costs and increasing access to lifesaving medications.

Source: FDA Center for Drug Evaluation and Research - What's New - March 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news